Ron Do, PhD, associate professor, Charles Bronfman Institute for Personalized Medicine at Mount Sinai, and Iain Forrest, MD-PhD candidate in Dr Do’s lab, discuss their hopes for their findings and how genetic data are being used in health care.
Ron Do, PhD, associate professor, Charles Bronfman Institute for Personalized Medicine at Mount Sinai, and Iain Forrest, MD-PhD candidate in Dr Do’s lab, discuss how they hope their recent study findings on penetrance of pathogenic and loss-of-function clinical variants can be used and how genetic data are being used in health care.
Transcript
How do you hope the results of your study will be used?
Do: I'll just say, for this study, we wanted to bring attention to the fact that penetrance appeared variable but generally low and penetrance wasn't necessarily concordant with pathogenicity labels. Penetrance doesn't necessarily mean the same thing as pathogenicity.
Forrest: Adding onto that, we also hope that this study will raise important discussions and dialogue about whether a new type of classification system—one based on penetrance, perhaps—to assess disease risk of variants is warranted and this could actually complement the current system based on pathogenicity, which is a categorical system.
Are we approaching any milestones in the understanding of genetic variants?
Do: We feel that this study is a good first step to understanding the disease risk, or penetrance, of genetic variants. However, more research is needed to calculate penetrance in a much larger number of samples to obtain more accurate penetrance estimates at the variant level.
Forrest: The milestone that we're hitting is that genetic data are being used increasingly inside health care. Improving the precision of our interpretations of variants with penetrance will aid in the integration of an individual's genetic data in their health care and help achieve personalized medicine, whereby an individual's unique sequence of DNA can actually shape their clinical care.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More